Diosmin Has Application in Preventing Neuropathy in Diabetics
September 18, 2006 - News
Comments
PARIS—In an intervention study conducted at Hospital Broussais, 13 outpatients (aged 39 to 67) with diabetes suffering from microcirculatory disorders were treated with 2 mg/d of Daflon, a micronized flavonoid fraction (90 percent diosmin and 10 percent flavonoid), for one month. Daflon supplementation increased capillary permeability in all cases, while 12 out of 13 cases showed normalization of albumin retention, and it normalized abnormal pathological lymphatic fluctuations in six patients. In a parallel group of 15 patients not treated with Daflon, the initially abnormal test remained abnormal five to 48 months later in all patients.

Diosmin, a member of the flavonoid family, is synthesized from Hesperidin and has been used for more than 30 years as a phlebotonic and vascular-protecting agent. The study was published in International Angiology (8:27-29, 2006) (www.nature.com/ijo/index.html).

Comments
comments powered by Disqus
Related News
News
Vitamin E tocotrienol supplemented with antioxidant polyphenols and niacin may improve inflammatory
News
According to a study published in the journal Chemico-Biological Interactions (doi:
News
An unpublished study by Nutra Canada suggests polyphenol liquid supplements from strawberries and
News
SALCITAL by Olive Lifesciences may benefit pre-diabetes management and mild to moderate
News
Two new studies showed Resveratrol's effects on body weight, blood pressure, cholesterol and